Long-Term Results : Patients using GLP-1 medications like Semaglutide or Tirzepatide often achieve 10-20% body weight reduction over the course of 6 months to 1 year , depending on individual factors like adherence to the medication, diet, and activity levels
Covering weight loss medications will be a significant expenditure for payers on the pharmacy benefit but could potentially result in long-term savings. Arguments against coverage aside from the steep cost include the lack of historical data on efficacy and reports of gastrointestinal disturbances such as constipation, diarrhea, nausea, vomiting and severe abdominal pain
10.1152/ajpregu.1996.271.4.R848 87
(GP-diagnosed, serum level below 150 pmol/L): Three injections over the first two weeks, then 1000mcg every two to three months
Findings in animal studies don't always translate to humans, but these drugs are contraindicated (not recommended) for those with a family history of medullary thyroid carcinoma (MTC)
The scale measures everything: water, glycogen, food in transit, muscle, fat